Skip to main content

Table 1 Clinical and hormonal characteristics of the subjects

From: Protein expression of PKCZ (Protein Kinase C Zeta), Munc18c, and Syntaxin-4 in the insulin pathway in endometria of patients with polycystic ovary syndrome (PCOS)

 

Control NPE

PCOSE-IR

AGE

39.7 ± 1.2

27.2 ± 0.6*

BMI

29.7 ± 2

32.7 ± 0.9

Testosterone (ng/dL)

0.4 ± 0.1

0.8 ± 0.1*

SHBG (nmol/L)

51.7 ± 9.5

24.2 ± 2.1*

FAI

3.7 ± 0.7

13.5 ± 1.6*

Estradiol (pmol/L)

270.7 ± 22.4

228.3 ± 3.5

Progesterone (nmol/L)

2.2 ± 0.3

1.9 ± 0.1

17-OH-Progesterone (ng/mL)

1.4 ± 0.3

19 ± 0.2

Androstenedione (ng/mL)

0.6 ± 0.2

2.8 ± 0.2*

  1. The values are expressed as mean ± SEM. *p < 0.05 NPE vs PCOSE-IR Blood samples from women during their normal proliferative phase (NPE) and from women with Polycystic Ovarian Syndrome and Insulin Resistance (PCOSE-IR). n = 6 for each studied group. BMI Body Mass Index, FAI Free Androgen Index, FP Follicular Phase, LP Luteal Phase
Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us